https://www.selleckchem.com/products/tmp269.html
Introduction The effectiveness of basal insulin (BI) or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in providing glycemic control in patients with type 2 diabetes (T2D) in Japanese routine practice is not well known. This real-world observational study evaluated the probability of achieving glycemic control in Japanese patients with T2D uncontrolled by oral antidiabetic drugs (OADs) who initiated BI or GLP-1 RA therapy. Methods Patients with T2D aged ≥ 18 years initiating BI or GLP-1 RA therapy following treatment with OADs wer
पसंद करना
टिप्पणी
शेयर करना
